Modern view on the treatment and prevention of gestational diabetes mellitus
AbstractThe article presents modern approaches to drug therapy of gestational diabetes mellitus. Insulin therapy, use of oral hypoglycemic drugs and dietary supplements for the treatment and prevention of this disease are considered in detail. A comparative assessment of each of the proposed treatment options was carried out.
Keywords:gestational diabetes mellitus; pregnancy; insulin therapy; metformin; glibenclamide; vitamin D; myo-inositol
Funding. The authors received no financial support for the authorship and publication of this article.
Conflict of interest. The authors declare no conflict of interest.
Contribution. Text writing – Kyrtikov S.I., Bekbaeva I.V., Akhmatova A.N.; literature search – Kuzmina E.A., Mukovnikova E.V., Orazmuradova A.A., Apresyan A.A.
For citation: Kyrtikov S.I., Bekbaeva I.V., Akhmatova A.N., Kuzmina E.A., Mukovnikova E.V., Orazmuradova A.A., Apresyan A.A. Modern view on the treatment and prevention of gestational diabetes mellitus. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2023; 11. Supplement: 115–21. DOI: https://doi.org/10.33029/2303-9698-2023-11-suppl-115-121 (in Russian)
REFERENCES
1. Russian Association of Endocrinologists, Russian Society of Obstetricians and Gynecologists. Gestational diabetes mellitus. Diagnosis, treatment, obstetric tactics, postpartum observation. Clinical guidelines. 2020. (in Russian)
2. Chaplygina E.V., Guzhvina E.N., Bolgova M.Yu., Pechenkin V.G. Causes of gestational diabetes mellitus. International Journal of Medicine and Psychology. 2021; 4 (3): 140–8. (in Russian)
3. McIntyre H.D., Catalano P., Zhang C., Desoye G., Mathiesen E.R., Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019; 5 (1): 47. DOI: https://doi.org/10.1038/s41572-019-0098-8 PMID: 31296866.
4. Li X., Zhang W., Lin J., Liu H., Yang Z., Teng Y., et al. Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases. J Clin Hypertens (Greenwich). 2018; 20 (6): 1049–57. DOI: https://doi.org/10.1111/jch.13302
5. Szmuilowicz E.D., Josefson J.L., Metzger B.E. Gestational diabetes mellitus. Endocrinol Metab Clin North Am. 2019; 48 (3): 479–93. DOI: https://doi.org/10.1016/j.ecl.2019.05.001
6. Oskovi-Kaplan Z.A., Ozgu-Erdinc A.S. Management of gestational diabetes mellitus. Adv Exp Med Biol. 2021; 1307: 257–72. DOI: https://doi.org/10.1007/5584_2020_552 PMID: 32548833.
7. American Diabetes Association Professional Practice Committee; American Diabetes Association Professional Practice Committee; Draznin B., Aroda V.R., Bakris G., Benson G., Brown F.M., Freeman R., et al. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022; 45 (suppl 1): S232–43. DOI: https://doi.org/10.2337/dc22-S015 PMID: 34964864.
8. Committee on Practice Bulletins – Obstetrics. ACOG Practice Bulletin No. 190. Gestational diabetes mellitus. Obstet Gynecol. 2018; 131 (2): e49–64.
9. Patti A.M., Giglio R.V., Pafili K., Rizzo M., Papanas N. Pharmacotherapy for gestational diabetes. Expert Opin Pharmacother. 2018; 19 (13): 1407–14. DOI: https://doi.org/10.1080/14656566.2018.1509955 Epub 2018 Aug 23. PMID: 30136869.
10. Pintaudi B., Bonomo M.A. Pharmacological treatment of gestational diabetes mellitus: when lifestyle intervention is not enough. Gestational Diabetes. 2020; 28: 61–75.
11. Mecacci F., Lisi F., Vannuccini S., Ottanelli S., Rambaldi M.P., Serena C., et al. Different gestational diabetes phenotypes: which insulin regimen fits better? Front Endocrinol (Lausanne). 2021; 12: 630903. DOI: https://doi.org/10.3389/fendo.2021.630903 PMID: 33767671; PMCID: PMC7985539.
12. Norgaard K., Sukumar N., Rafnsson S.B., Saravanan P. Efficacy and safety of rapid-acting insulin analogs in special populations with type 1 diabetes or gestational diabetes: systematic review and meta-analysis. Diabetes Ther. 2018; 9 (3): 891–917. DOI: https://doi.org/10.1007/s13300-018-0411-7 Epub 2018 Apr 5. PMID: 29623593; PMCID: PMC5984914.
13. Mukherjee S.M., Dawson A. Diabetes: how to manage gestational diabetes mellitus. Drugs Context. 2022; 11: 2021-9-12. DOI: https://doi.org/10.7573/dic.2021-9-12 PMID: 35775071; PMCID: PMC9205567.
14. Athanasiadou K.I., Paschou S.A., Stamatopoulos T., Papakonstantinou E., Haidich A.B., Goulis D.G. Safety and efficacy of insulin detemir versus NPH in the treatment of diabetes during pregnancy: Systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2022; 190: 110020. DOI: https://doi.org/10.1016/j.diabres.2022.110020 Epub 2022 Jul 22. PMID: 35878788.
15. Radzinsky V.E., Botasheva T.L., Papysheva O.V., et al. Obesity. Diabetes. Pregnancy. versions and counterversions. Clinical practices. Perspectives. Moscow: GEOTAR-Media, 2020: 528 p. DOI: https://doi.org/10.33029/9704-5442-8-OBE-2020-1-528 (in Russian)
16. Jethwani P., Saboo B., Jethwani L., Chawla R., Maheshwari A., Agarwal S., et al. Use of insulin glargine during pregnancy: A review. Diabetes Metab Syndr. 2021; 15 (1): 379–84. DOI: https://doi.org/10.1016/j.dsx.2021.01.012 Epub 2021 Jan 22. PMID: 33540243.
17. Wang J., Ji X., Liu T., Zhao N. Maternal and neonatal outcomes with the use of long acting, compared to intermediate acting basal insulin (NPH) for managing diabetes during pregnancy: a systematic review and meta-analysis. Diabetol Metab Syndr. 2022; 14 (1): 154. DOI: https://doi.org/10.1186/s13098-022-00925-7 PMID: 36271431; PMCID: PMC9585834.
18. Dedov I.I., Shestakova M.V., Mayorov A.Yu. Standards of specialized diabetes care – 10th edition (expanded) Moscow, 2021. DOI: https://doi.org/10.14341/DM12802 (in Russian)
19. Alyautdin R.N. Pharmacology: Textbook. 6th ed., reprint. and additional. Moscow: GEOTAR-Media, 2022: 1104 p. ISBN 978-5-9704-6819-7. (in Russian)
20. Johns E.C., Denison F.C., Norman J.E., Reynolds R.M. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018; 29 (11): 743–54. DOI: https://doi.org/10.1016/j.tem.2018.09.004 Epub 2018 Oct 5. PMID: 30297319.
21. Given J.E., Loane M., Garne E., Addor M.C., Bakker M., Bertaut-Nativel B., et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ. 2018; 361: k2477. DOI: https://doi.org/10.1136/bmj.k2477 PMID: 29941493; PMCID: PMC6016021.
22. Priya G., Kalra S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context. 2018; 7: 212523. DOI: https://doi.org/10.7573/dic.212523 PMID: 29942340; PMCID: PMC6012930.
23. Bidhendi Yarandi R., Behboudi-Gandevani S., Amiri M., Ramezani Tehrani F. Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression. Diabetol Metab Syndr. 2019; 11: 58. DOI: https://doi.org/10.1186/s13098-019-0453-7 PMID: 31367235; PMCID: PMC6651943.
24. Vanlalhruaii, Dasgupta R., Ramachandran R., Mathews J.E., Regi A., Thomas N., et al. How safe is metformin when initiated in early pregnancy? A retrospective 5-year study of pregnant women with gestational diabetes mellitus from India. Diabetes Res Clin Pract. 2018; 137: 47–55. DOI: https://doi.org/10.1016/j.diabres.2018.01.002 Epub 2018 Jan 8. PMID: 29325773.
25. Rowan J.A., Rush E.C., Plank L.D., et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care. 2018; 6: e000456.
26. Khin M.O., Gates S., Saravanan P. Predictors of metformin failure in gestational diabetes mellitus (GDM). Diabetes Metab Syndr. 2018; 12 (3): 405–10. DOI: https://doi.org/10.1016/j.dsx.2018.01.003 Epub 2018 Jan 31. PMID: 29576523.
27. Benido Silva V., Fonseca L., Pereira M.T., Vilaverde J., Pinto C., Pichel F., et al. Predictors of metformin monotherapy failure in gestational diabetes mellitus. Endocr Connect. 2022; 11 (5): e210540. DOI: https://doi.org/10.1530/EC-21-0540 PMID: 35521811; PMCID: PMC9175587.
28. Liao M.Z., Flood Nichols S.K., Ahmed M., Clark S., Hankins G.D., Caritis S., et al. Effects of pregnancy on the pharmacokinetics of metformin. Drug Metab Dispos. 2020; 48 (4): 264–71. DOI: https://doi.org/10.1124/dmd.119.088435 Epub 2020 Jan 24. PMID: 31980499; PMCID: PMC7076518.
29. Patti A.M., Giglio R.V., Pafili K., Rizzo M., Papanas N. Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? Ann Transl Med. 2018; 6 (suppl 1): S79. DOI: https://doi.org/10.21037/atm.2018.10.60 PMID: 30613654; PMCID: PMC6291594.
30. Shmuel E., Krispin E., Toledano Y., Chen R., Wiznitzer A., Hadar E. Pharmacological therapy in gestational diabetes – a comparison between insulin and oral therapy. J Matern Fetal Neonatal Med. 2022; 35 (25): 5071–9. DOI: https://doi.org/10.1080/14767058.2021.1875208 Epub 2021 Jan 18. PMID: 33461358.
31. Nachum Z., Zafran N., Salim R., et al. Glyburide versus metformin and their combination for the treatment of gestational diabetes mellitus: a randomized controlled study. Diabetes Care. 2017; 40: 332–7.
32. Tarry-Adkins J.L., Aiken C.E., Ozanne S.E. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. PLoS Med. 2020; 17 (5): e1003126. DOI: https://doi.org/10.1371/journal.pmed.1003126 PMID: 32442232; PMCID: PMC7244100.
33. Liang H.L., Ma S.J., Xiao Y.N., Tan H.Z. Comparative efficacy and safety of oral antidiabetic drugs and insulin in treating gestational diabetes mellitus: An updated PRISMA-compliant network meta-analysis. Medicine (Baltimore). 2017; 96 (38): e7939. DOI: https://doi.org/10.1097/MD.0000000000007939 PMID: 28930827; PMCID: PMC5617694.
34. Díaz P., Dimasuay K.G., Koele-Schmidt L., Jang B., Barbour L.A., Jansson T., et al. Glyburide treatment in gestational diabetes is associated with increased placental glucose transporter 1 expression and higher birth weight. Placenta. 2017; 57: 52–9. DOI: https://doi.org/10.1016/j.placenta.2017.05.016 Epub 2017 May 31. PMID: 28864019.
35. Sénat M.V., Affres H., Letourneau A., Coustols-Valat M., Cazaubiel M., Legardeur H., et al.; Groupe de Recherche en Obstétrique et Gynécologie (GROG). Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: A randomized clinical trial. JAMA. 2018; 319 (17): 1773–80. DOI: https://doi.org/10.1001/jama.2018.4072 PMID: 29715355; PMCID: PMC6583037.
36. Mierzyński R., Poniedziałek-Czajkowska E., Sotowski M., Szydełko-Gorzkowicz M. Nutrition as prevention factor of gestational diabetes mellitus: A narrative review. Nutrients. 2021; 13 (11): 3787. DOI: https://doi.org/10.3390/nu13113787 PMID: 34836042; PMCID: PMC8625817.
37. Rasmussen L., Poulsen C.W., Kampmann U., Smedegaard S.B., Ovesen P.G., Fuglsang J. Diet and healthy lifestyle in the management of gestational diabetes mellitus. Nutrients. 2020; 12 (10): 3050. DOI: https://doi.org/10.3390/nu12103050 PMID: 33036170; PMCID: PMC7599681.
38. Szymczak-Pajor I., Śliwińska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients. 2019; 11 (4): 794. DOI: https://doi.org/10.3390/nu11040794 PMID: 30959886; PMCID: PMC6520736.
39. Akbari M., Moosazaheh M., Lankarani K.B., et al. The effects of vitamin D supplementation on glucose metabolism and lipid profiles in patients with gestational diabetes: A systematic review and meta-analysis of randomized controlled trials. Horm Metab Res. 2017; 49: 647–53.
40. Zhang Y., Gong Y., Xue H., Xiong J., Cheng G. Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effect. BJOG. 2018; 125 (7): 784–93. DOI: https://doi.org/10.1111/1471-0528.15060 Epub 2018 Jan 18. PMID: 29244241.
41. Parrettini S., Caroli A., Torlone E. Nutrition and metabolic adaptations in physiological and complicated pregnancy: Focus on obesity and gestational diabetes. Front Endocrinol (Lausanne). 2020; 11: 611929. DOI: https://doi.org/10.3389/fendo.2020.611929 PMID: 33424775; PMCID: PMC7793966.
42. Watkins O.C., Yong H.E.J., Sharma N., Chan S.-Y. A review of the role of inositols in conditions of insulin dysregulation and in uncomplicated and pathological pregnancy. Crit Rev Food Sci Nutr. 2022; 62 (6): 1626–73. DOI: https://doi.org/10.1080/10408398.2020.1845604
43. Amaefule C.E., Drymoussi Z., Gonzalez Carreras F.J., Pardo Llorente M.D.C., Lanz D., Dodds J., et al. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study. BMJ Open. 2022; 12 (3): e050110. DOI: https://doi.org/10.1136/bmjopen-2021-050110 PMID: 35277398; PMCID: PMC8919454.
44. Farren M., Daly N., McKeating A., et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: A randomized controlled trial. Diabetes Care. 2017; 40: 759–63.
45. Liu X.N., Pang J. A retrospective study of supplemental iron intake in singleton pregnancy women with risk of developing gestational diabetes mellitus. Medicine (Baltimore). 2018; 97: e10819.